Wander, P.; Arentsen-Peters, S.T.C.J.M.; Vrenken, K.S.; PinhanÒ«os, S.M.; Koopmans, B.; Dolman, M.E.M.; Jones, L.; Garrido Castro, P.; Schneider, P.; Kerstjens, M.;
et al. High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines 2022, 10, 638.
https://doi.org/10.3390/biomedicines10030638
AMA Style
Wander P, Arentsen-Peters STCJM, Vrenken KS, PinhanÒ«os SM, Koopmans B, Dolman MEM, Jones L, Garrido Castro P, Schneider P, Kerstjens M,
et al. High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines. 2022; 10(3):638.
https://doi.org/10.3390/biomedicines10030638
Chicago/Turabian Style
Wander, Priscilla, Susan T. C. J. M. Arentsen-Peters, Kirsten S. Vrenken, Sandra Mimoso PinhanÒ«os, Bianca Koopmans, M. Emmy M. Dolman, Luke Jones, Patricia Garrido Castro, Pauline Schneider, Mark Kerstjens,
and et al. 2022. "High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling" Biomedicines 10, no. 3: 638.
https://doi.org/10.3390/biomedicines10030638
APA Style
Wander, P., Arentsen-Peters, S. T. C. J. M., Vrenken, K. S., PinhanÒ«os, S. M., Koopmans, B., Dolman, M. E. M., Jones, L., Garrido Castro, P., Schneider, P., Kerstjens, M., Molenaar, J. J., Pieters, R., Zwaan, C. M., & Stam, R. W.
(2022). High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling. Biomedicines, 10(3), 638.
https://doi.org/10.3390/biomedicines10030638
